January 30, 2019
GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)
Read More
January 30, 2019
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Read More
January 30, 2019
TroVax Renal Immunotherapy Survival Trial
Read More
January 30, 2019
TroVax Renal Immunotherapy Survival Trial
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma
Read More
January 30, 2019
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
Read More
January 30, 2019
An Extension Treatment Protocol for Subjects Who Have Participated in a Phase 3 Study of Tivozanib Versus Sorafenib in Renal Cell Carcinoma (Protocol AV-951-09-301)
Read More
January 30, 2019
A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
Read More
Load More
X